Corient Private Wealth LP lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 22.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,596 shares of the company's stock after selling 16,098 shares during the quarter. Corient Private Wealth LP's holdings in GE HealthCare Technologies were worth $3,624,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Freestone Grove Partners LP acquired a new position in shares of GE HealthCare Technologies in the second quarter valued at $1,020,000. Man Group plc lifted its stake in shares of GE HealthCare Technologies by 438.6% during the 2nd quarter. Man Group plc now owns 29,300 shares of the company's stock worth $1,875,000 after buying an additional 23,860 shares during the last quarter. First Bancorp Inc ME acquired a new stake in shares of GE HealthCare Technologies during the 2nd quarter worth about $56,000. Roberts Glore & Co. Inc. IL bought a new stake in shares of GE HealthCare Technologies during the 2nd quarter worth about $300,000. Finally, Jupiter Topco LLC bought a new stake in shares of GE HealthCare Technologies during the 2nd quarter worth about $3,821,000. Institutional investors own 82.06% of the company's stock.
Analysts Set New Price Targets
GEHC has been the subject of a number of research reports. BMO Capital Markets began coverage on GE HealthCare Technologies in a report on Wednesday, July 8th. They set a "market perform" rating and a $70.00 target price for the company. Hovde Group initiated coverage on shares of GE HealthCare Technologies in a research note on Friday, July 17th. They issued a "market perform" rating and a $14.00 price target on the stock. Citigroup upped their price target on shares of GE HealthCare Technologies from $69.00 to $75.00 and gave the company a "neutral" rating in a research note on Thursday, July 30th. Argus dropped their price objective on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a "buy" rating for the company in a research note on Tuesday, May 19th. Finally, UBS Group boosted their price objective on shares of GE HealthCare Technologies from $67.00 to $73.00 and gave the company a "neutral" rating in a report on Friday, July 31st. Ten investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company's stock. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of "Hold" and a consensus price target of $77.73.
Read Our Latest Stock Report on GEHC
GE HealthCare Technologies Stock Performance
NASDAQ:GEHC opened at $70.42 on Wednesday. The stock has a fifty day moving average price of $68.02 and a 200-day moving average price of $69.14. The company has a market cap of $31.81 billion, a price-to-earnings ratio of 16.15, a PEG ratio of 1.88 and a beta of 0.70. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.97 and a current ratio of 1.26. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, topping analysts' consensus estimates of $1.04 by $0.09. The company had revenue of $5.29 billion for the quarter, compared to analysts' expectations of $5.26 billion. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.GE HealthCare Technologies's revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the business earned $1.06 earnings per share. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.93 EPS for the current fiscal year.
GE HealthCare Technologies Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Friday, July 24th were given a $0.035 dividend. The ex-dividend date was Friday, July 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies's payout ratio is presently 3.21%.
GE HealthCare Technologies Company Profile
(
Free Report)
GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
